Pancreatic Cancer Research

ResearcherUniversity of TorontoActive in the last 2 years

Michael Jonathon Raphael

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3301-2388; OpenAlex author ID A5053112746. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 5

  1. The association between cardiovascular medication use and survival in patients with advanced pancreatic adenocarcinoma. Last author DOI 10.1177/17588359261449094↗
  2. Focused ultrasound and concurrent chemotherapy for the treatment of advanced pancreatic cancer: A systematic review. Co-author DOI 10.1002/jso.27832↗
  3. Comparative Effectiveness of FOLFIRINOX Versus Gemcitabine and Nab-paclitaxel in Initially Unresectable Locally Advanced Pancreatic Cancer: A Population-based … Co-author DOI 10.1016/j.clon.2023.02.008↗
  4. Real-World Cost-Effectiveness of First-Line Gemcitabine Plus Nab-Paclitaxel vs FOLFIRINOX in Patients With Advanced Pancreatic Cancer. Co-author DOI 10.1093/jncics/pkac047↗
  5. The Association of Drug-Funding Reimbursement With Survival Outcomes and Use of New Systemic Therapies Among Patients With Advanced Pancreatic Cancer. Co-author DOI 10.1001/jamanetworkopen.2021.33388↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kelvin Chan · 4 shared papers, 2021–2026 · strength 0.78
  2. Natalie G. Coburn · 2 shared papers, 2023–2026 · strength 0.53
  3. Wei Fang Dai · 3 shared papers, 2021–2023 · strength 0.42
  4. Michail N. Mavros · 1 shared paper, 2026 · strength 0.36
  5. Sean Bennett · 1 shared paper, 2024 · strength 0.31
  6. Paul Jack Karanicolas · 1 shared paper, 2024 · strength 0.31
  7. James Biagi · 1 shared paper, 2023 · strength 0.17
  8. Vanessa Sarah Arciero · 1 shared paper, 2022 · strength 0.13
  9. Ambica Parmar · 1 shared paper, 2022 · strength 0.13
  10. Nicole Mittmann · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.